EHA 2021

0:06:28

Highlights of EHA 2021

0:00:52

Benefits of a virtual EHA 2021 meeting

0:01:18

Why should you join #EHA2021 Virtual? Hear from Prof K Döhner (EHA Board Member)

0:00:25

Why should you join #EHA2021 Virtual? Hear from Prof K Grønbæk (EHA Board Member)

0:01:02

Biomarker updates at EHA 2021

0:01:14

Looking forward to EHA 2021

0:01:11

EHA 2021 updates on MPNs coming soon

0:03:03

Key updates on MPNs from EHA 2021

0:02:37

Inhibidores BTK para LLC en EHA 2021

0:06:53

EHA Video Newsletter 5-2021(DE) mit Tobias Bretzel, EUROPEAN ROTORS

0:04:24

EHA 2021 2022 Banquet Video

0:02:13

Key transplantation updates at EHA 2021

0:06:17

Key communications on GvHD at EHA 2021

0:00:22

Blinatumomab plus ponatinib for ALL update coming soon at EHA 2021

0:00:56

Why should you join #EHA2021 Virtual? Hear from Prof J Gribben (EHA Executive Board, President)

0:34:36

Highlights from ASCO / EHA 2021: latest updates on myeloma

1:29:16

EHA 2021 - John Wallis Presidential Address

2:02:41

EHA 2021 - Dissertation Session

2:04:23

EHA WEHD LiveChat recording 2021

0:00:58

ASH-EHA Joint Symposium: ASH News TV 2021

0:01:17

Updates on BTK inhibitors for CLL at EHA 2021

0:01:42

Exciting myeloma updates coming soon at EHA 2021

0:00:58

Podsumowanie najnowszych doniesień z EHA 2021 22 czerwca 2021 r. godz. 18:00